Viewing Study NCT03492658


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-17 @ 7:39 AM
Study NCT ID: NCT03492658
Status: COMPLETED
Last Update Posted: 2022-08-17
First Post: 2018-04-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
Sponsor: Leiden University Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
None Rheumatic Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None abatacept View
None ACPA expressing B cells View